Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum

Abstract Background Pancreatic cancer is one of the most aggressive malignancies with a 5-year relative survival rate of only 13%. Its poor prognosis is largely attributed to the lack of reliable tools for early detection. Current diagnostic standards rely on imaging methods that are invasive, costl...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ondřej Peterka, Robert Jirásko, Zuzana Dolečková, Mária Dosoudilová, Josef Bártl, Jakub Idkowiak, Ondřej Slavíček, Karolína Pešková, Milan Vošmik, Beatrice Mohelníková-Duchoňová, Irena Kozubíková, Martin Loveček, Ondřej Urban, Jan Trna, Petr Karásek, Bohuslav Melichar, Michal Holčapek
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2026-03-01
Sarja:	Communications Medicine
Linkit:	https://doi.org/10.1038/s43856-026-01445-5
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!